Found 86 matching trials
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer PHASE2 Researchers conducting this study hope to learn about the safety and effect...
Show More Location
University of Chicago Comprehensive Cancer Center
Learn More & Join Trial
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer PHASE2 Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Show More Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP) PHASE1 Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy...
Show More Location
Piedmont Cancer Institute, P.C.
Learn More & Join Trial
A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer N/A This is an observational study in which patient data from the past on men w...
Show More Learn More & Join Trial
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer PHASE2 This is a prospective, open-label, multi-center seamless phase II to phase ...
Show More Location
VA Long Beach Healthcare System, Long Beach, CA
Learn More & Join Trial
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer PHASE3 The aim is to investigate whether the addition of short-term androgen depri...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) PHASE2 This is a multicenter, open-label, randomized, two-arm, phase II clinical t...
Show More Location
Institut Català d'Oncologia Badalona
Learn More & Join Trial
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer PHASE4 The objective of this study was to compare the efficacy and safety of the c...
Show More Learn More & Join Trial
START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC NA Phase III study of stereotactic body radiation therapy (SBRT) plus standard...
Show More Location
Hospital Universitario Ramón y Cajal
Learn More & Join Trial
Testosterone Therapy in Castration Resistant Prostate Cancer EARLY_PHASE1 This is an open-labeled, single-arm, interventional pilot study. It is bein...
Show More Location
University of Colorado Hospital
Learn More & Join Trial